Esteban Braggio

10.3k total citations · 2 hit papers
154 papers, 4.1k citations indexed

About

Esteban Braggio is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Esteban Braggio has authored 154 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 73 papers in Hematology and 65 papers in Genetics. Recurrent topics in Esteban Braggio's work include Multiple Myeloma Research and Treatments (67 papers), Chronic Lymphocytic Leukemia Research (59 papers) and Protein Degradation and Inhibitors (44 papers). Esteban Braggio is often cited by papers focused on Multiple Myeloma Research and Treatments (67 papers), Chronic Lymphocytic Leukemia Research (59 papers) and Protein Degradation and Inhibitors (44 papers). Esteban Braggio collaborates with scholars based in United States, Brazil and Germany. Esteban Braggio's co-authors include Rafaël Fonseca, A. Keith Stewart, P. Leif Bergsagel, Chang-Xin Shi, Laura A. Bruins, Jessica Schmidt, Yuan Xiao Zhu, Scott Van Wier, Jan B. Egan and Jonathan J. Keats and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Esteban Braggio

147 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide

2011 461 citations Yuan Xiao Zhu, Esteban Braggio et al. Blood profile →
Clonal competition with alternating dominance in multiple myeloma

2012 456 citations Jonathan J. Keats, Marta Chesi et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Esteban Braggio United States	33	2.6k	2.2k	1.2k	881	873	154	4.1k
Marc Loriaux United States	34	2.0k 0.8×	2.2k 1.0×	808 0.7×	510 0.6×	2.1k 2.4×	98	4.5k
Philip Beer United Kingdom	32	2.4k 0.9×	2.3k 1.0×	722 0.6×	388 0.4×	2.7k 3.1×	87	4.6k
Masashi Sanada Japan	33	2.2k 0.9×	1.3k 0.6×	633 0.5×	441 0.5×	630 0.7×	118	4.1k
Debra M. Lillington United Kingdom	27	1.2k 0.5×	1.3k 0.6×	631 0.5×	640 0.7×	486 0.6×	50	3.0k
Claudia Voena Italy	29	1.4k 0.6×	992 0.4×	1.2k 1.0×	768 0.9×	427 0.5×	57	3.2k
WM Crist United States	46	1.9k 0.7×	3.3k 1.5×	819 0.7×	764 0.9×	811 0.9×	100	5.9k
Michael H. Tomasson United States	32	1.6k 0.6×	1.8k 0.8×	1.3k 1.0×	265 0.3×	659 0.8×	116	3.5k
Marta Chesi United States	40	5.2k 2.0×	4.0k 1.8×	2.2k 1.8×	654 0.7×	817 0.9×	119	7.2k
Christian Bastard France	46	2.5k 1.0×	1.9k 0.9×	2.3k 1.9×	3.1k 3.5×	2.0k 2.3×	152	6.4k
Brian Van Ness United States	35	2.2k 0.9×	2.4k 1.1×	1.3k 1.0×	293 0.3×	581 0.7×	83	3.7k

Countries citing papers authored by Esteban Braggio

Since Specialization

Citations

This map shows the geographic impact of Esteban Braggio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esteban Braggio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esteban Braggio more than expected).

Fields of papers citing papers by Esteban Braggio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esteban Braggio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esteban Braggio. The network helps show where Esteban Braggio may publish in the future.

Co-authorship network of co-authors of Esteban Braggio

This figure shows the co-authorship network connecting the top 25 collaborators of Esteban Braggio. A scholar is included among the top collaborators of Esteban Braggio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esteban Braggio. Esteban Braggio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Qianqian, Yuan Gao, Sutapa Sinha, et al.. (2024). Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia. SHILAP Revista de lepidopterología. 2(1). 100059–100059.

Zanwar, Saurabh, Martha M. Howe, Moritz Binder, et al.. (2024). The Mutational Landscape of Extramedullary Multiple Myeloma Reveals Novel Biologic Insights and Potential Therapeutic Targets for Exploration. Blood. 144(Supplement 1). 2744–2744. 1 indexed citations

O’Brien, Daniel R., Erik Jessen, Cecília Bonolo de Campos, et al.. (2024). Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations. Cancers. 16(13). 2450–2450. 2 indexed citations

Giacopelli, Brian, Kari G. Rabe, Yue-Zhong Wu, et al.. (2024). Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature. Blood. 143(17). 1752–1757. 2 indexed citations

Sekar, Aswin, Sameer A. Parikh, Giulio Genovese, et al.. (2024). Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL). Blood Cancer Journal. 14(1). 193–193. 3 indexed citations

Parikh, Sameer A., Sara J. Achenbach, Kari G. Rabe, et al.. (2024). Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis. Journal of Clinical Oncology. 42(35). 4153–4162. 2 indexed citations

Mwangi, Raphael, Dennis P. Robinson, Sara J. Achenbach, et al.. (2024). Abstract 6152: Genetic associations with hematologic malignancies: An evaluation of CLL polygenic risk score and MBL status in the Mayo Clinic Biobank Cohort. Cancer Research. 84(6_Supplement). 6152–6152.

Boddicker, Nicholas, Sara J. Achenbach, Sameer A. Parikh, et al.. (2022). Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis. Leukemia. 36(5). 1404–1407. 3 indexed citations

Slager, Susan L., Sameer A. Parikh, Sara J. Achenbach, et al.. (2022). Progression and survival of MBL: a screening study of 10 139 individuals. Blood. 140(15). 1702–1709. 13 indexed citations

10.

Parikh, Sameer A., Kari G. Rabe, Neil E. Kay, et al.. (2021). The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL. Blood. 138(2). 149–159. 23 indexed citations

11.

Shi, Chang-Xin, Yuan Xiao Zhu, Laura A. Bruins, et al.. (2020). Proteasome Subunits Differentially Control Myeloma Cell Viability and Proteasome Inhibitor Sensitivity. Molecular Cancer Research. 18(10). 1453–1464. 23 indexed citations

12.

Yan, Huihuang, Shulan Tian, Geffen Kleinstern, et al.. (2020). Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk loci. Human Molecular Genetics. 29(16). 2761–2774. 5 indexed citations

13.

Smadbeck, James B., Jess F. Peterson, Kathryn E. Pearce, et al.. (2019). Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma. Blood Cancer Journal. 9(12). 103–103. 29 indexed citations

14.

Vaisitti, Tiziana, Esteban Braggio, John N. Allan, et al.. (2018). Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses. Cancer Research. 78(13). 3413–3420. 33 indexed citations

15.

Wenzl, Kerstin, Michelle K. Manske, Vivekananda Sarangi, et al.. (2018). Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma. Blood Cancer Journal. 8(10). 97–97. 24 indexed citations

16.

Shi, Chang-Xin, K. Martin Kortüm, Yuan Xiao Zhu, et al.. (2017). CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma. Molecular Cancer Therapeutics. 16(12). 2862–2870. 42 indexed citations

17.

Zhu, Yuan Xiao, Chang-Xin Shi, Laura A. Bruins, et al.. (2017). Loss of FAM46C Promotes Cell Survival in Myeloma. Cancer Research. 77(16). 4317–4327. 53 indexed citations

18.

Braggio, Esteban, Scott Van Wier, Juhi Ojha, et al.. (2015). Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. Clinical Cancer Research. 21(17). 3986–3994. 150 indexed citations

19.

Jiménez‐Zepeda, Víctor H., Esteban Braggio, & Rafaël Fonseca. (2013). Dissecting Karyotypic Patterns in Non-Hyperdiploid Multiple Myeloma: An Overview on the Karyotypic Evolution. Clinical Lymphoma Myeloma & Leukemia. 13(5). 552–558. 6 indexed citations

20.

Keats, Jonathan J., Marta Chesi, Jan B. Egan, et al.. (2012). Clonal competition with alternating dominance in multiple myeloma. Blood. 120(5). 1067–1076. 456 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact